• 1
    Prusiner SB, Scott MR, Dearmond SJ & Cohen FE (1998) Prion protein biology. Cell 93, 337348.
  • 2
    Christensen HM & Harris DA (2008) Prion protein lacks robust cytoprotective activity in cultured cells. Mol Neurodegeneration 3, 11.
  • 3
    Aguzzi A & Polymenidow M (2004) Mammalian prion biology. One century of evolving concepts. Cell 116, 313327.
  • 4
    Zhao Y, You H, Liu F, An H, Shi Y & Fan D (2002) Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 185, 211218.
  • 5
    Du JP, Jin XH, Shi YQ, Zhao YQ, Liu CJ, Cao YX, Qiao TD, Chen BJ & Fan DM (2003) The overexpression of prion protein in drug resistant gastric cancer cell line SGC7901/ADR and its significance. Zhonghua Yi Xue Za Zhi 83, 328332.
  • 6
    Du J, Pan Y, Shi Y, Guo C, Jin X, Sun L, Liu N, Qiao T & Fan D (2005) Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int J Cancer 113, 213220.
  • 7
    Liang J, Pan YL, Ning XX, Sun LJ, Lan M, Hong L, Du JP, Liu N, Liu CJ, Qiao TD et al. (2006) Overexpression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol 27, 8491.
  • 8
    Liang J, Ge FL, Lu YY, Wang J, Zhai HH, Yao LP, Li TT, Ji Q, Guo XY, Liu ZX et al. (2006) Role of PrPc related to apoptosis. Experimental and Clinical Sciences International Journal 5, 1124.
  • 9
    Pan Y, Zhao L, Liang J, Liu J, Shi Y, Liu N, Zhang G, Jin H, Gao J, Xie H et al. (2006) Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 20, 18861888.
  • 10
    Akiyama H, Furukawa S, Wakisaka S & Maeda T (2006) Cartducin stimulates mesenchymal chondroprogenitor cell proliferation through both extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways. FEBS J 273, 22572263.
  • 11
    Han Z, Hong L, Wu K, Han S, Shen H, Liu C, Han Y & Fan D (2006) Reversal of multidrug resistance of gastric cancer cells by downregulation of Akt1 with Akt1 siRNA. J Exp Clin Cancer Res 25, 207212.
  • 12
    Schmalzbauer R, Eigenbrod S, Winoto-Morbach S, Xiang W, Schütze S, Bertsch U & Kretzschmar HA (2008) Evidence for an association of prion protein and sphingolipid-mediated signaling. J Neurochem 106, 14591470.
  • 13
    Liang J, Zhang DX, Pan YL, Shi YQ, Guo CC, Wang JB, Chen Y, Wang X, Liu J, Guo XG et al. (2007) Cellular prion protein promotes cell proliferation and G1/S transition of gastric cancer cells SGC7901 and AGS. FASEB J 28, 173180.
  • 14
    Diarra-Mehrpour M, Arrabal S, Jalil A, Pinson X, Gaudin C, Pietu G, Pitaval A, Ripoche H, Eloit M, Dormont D et al. (2004) Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res 64, 719727.
  • 15
    Meslin F, Hamaï A, Gao P, Jalil A, Cahuzac N, Chouaib S & Mehrpour M (2007) Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res 67, 1091010919.
  • 16
    Levenson VV, Davidovich IA & Roninson IB (2000) Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response. Cancer Res 60, 50275030.
  • 17
    Regev R, Katzir H, Yeheskely-Hayon D & Eytan GD (2007) Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane. FEBS J 274, 62046214.
  • 18
    Hao Z, Li X, Qiao T, Du R, Hong L & Fan D (2006) CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol Ther 5, 261266.
  • 19
    Du J, Shi Y, Pan Y, Jin X, Liu C, Liu N, Han Q, Lu Y, Qiao T & Fan D (2005) Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells. Cancer Biol Ther 4, 242247.
  • 20
    Hong L, Piao Y, Han Y, Wang J, Zhang X, Du Y, Cao S, Qiao T, Chen Z & Fan D (2005) Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther 4, 19361942.
  • 21
    Xu X, Chua CC, Gao J, Chua KW, Wang H, Hamdy RC & Chua BH (2008) Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway. Brain Res 1227, 1218.
  • 22
    Fantappiè O, Solazzo M, Lasagna N, Platini F, Tessitore L & Mazzanti R (2007) P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. Cancer Res 67, 49154923.
  • 23
    Santuccione A, Sytnyk V, Leshchyns’ka I & Schachner M (2005) Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 169, 341354.
  • 24
    Frossi B, Rivera J, Hirsch E & Pucillo C (2007) Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol 178, 25492555.
  • 25
    Kuo MT, Liu Z, Wei Y, Lin-Lee YC, Tatebe S, Mills GB & Unate H (2000) Induction of human MDR-1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling. Oncogene 21, 19451954.
  • 26
    An H, Zhou S & Fan D (1997) Establishment and characteristics of an adriamycin resistant human gastric carcinoma cell line. J Dig Dis Endosc 2, 108113.
  • 27
    Guo CC, Ding J, Yao LP, Sun L, Lin T, Song Y, Sun LJ & Fan DM (2005) Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer 116, 155160.